Parasites, Hosts and Diseases

The Korea Society for Parasitology and Tropical Medicine (대한기생충학·열대의학회)
권호 표지
DOI QR코드

DOI QR Code

A Case Report of Intravitreal Dexamethasone Implant with Exudative Retinal Detachment for Ocular Toxocariasis Treatment

  • Cai, Youran (Department of Ophthalmology, The First Affiliated Hospital of Guangxi Medical University) ;
  • Yang, Ye (Department of Ophthalmology, The First Affiliated Hospital of Guangxi Medical University) ;
  • Zhong, Xin (Department of Ophthalmology, The First Affiliated Hospital of Guangxi Medical University)
  • Received : 2022.01.24
  • Accepted : 2022.03.21
  • Published : 2022.04.30
Download PDF
⟨ Previous Next ⟩

Abstract

Toxocariasis is one of the most common geohelminth infections in several parts of the world. We describe a rare case of ocular toxocariasis with secondary exudative retinal detachment treated with albendazole and an intravitreal dexamethasone implant. A 13-year-old boy with counting finger vision was diagnosed with retinal vasculitis and exudative retinal detachment in his right eye. Fundoscopic examination revealed retinal hemorrhage, retinal vasculitis, and exudative retinal detachment. Serological test using serum and intraocular aqueous humor were positive for anti-Toxocara specific IgG antibodies. He received repeated doses of intravitreal dexamethasone implants combined with oral albendazole. A sequential follow-up optical coherence tomography revealed that the retina was successfully reattached. His visual acuity subsequently improved to 20/400.

Keywords

Acknowledgement

The case report did not require ethical approval. Written informed consent was obtained from the patient for the surgical procedure.

References

  1. Chen J, Liu Q, Liu GH, Zheng WB, Hong SJ, Sugiyama H, Zhu XQ, Elsheikha HM. Toxocariasis: a silent threat with a progressive public health impact. Infect Dis Poverty 2018; 7: 59. https://doi.org/10.1186/s40249-018-0437-0
  2. Auer H, Walochnik J. Toxocariasis and the clinical spectrum. Adv Parasitol 2020; 109: 111-130. http://doi.org/10.1016/bs.apar.2020.01.005
  3. Taylor MR. The epidemiology of ocular toxocariasis. J Helminthol 2001; 75: 109-118.
  4. Woodhall D, Starr MC, Montgomery SP, Jones JL, Lum F, Read RW, Moorthy RS. Ocular toxocariasis: epidemiologic, anatomic, and therapeutic variations based on a survey of ophthalmic subspecialists. Ophthalmology 2012; 119: 1211-1217. https://doi.org/10.1016/j.ophtha.2011.12.013
  5. Scaramuzzi M, Querques G, Spina CL, Lattanzio R, Bandello F. Repeated intravitreal dexamethasone implant (Ozurdex) for diabetic macular edema. Retina 2015; 35: 1216-1222. https://doi.org/10.1097/iae.0000000000000443
  6. Fassbender Adeniran JM, Jusufbegovic D, Schaal S. Common and rare ocular side-effects of the dexamethasone implant. Ocul Immunol Inflamm 2017; 25: 834-840. https://doi.org/10.1080/09273948.2016.1184284
  7. Hostovsky A, Muni RH, Eng KT, Mulhall D, Leung C, Kertes PJ. Intraoperative dexamethasone intravitreal implant (Ozurdex) in vitrectomy surgery for epiretinal membrane. Curr Eye Res 2020; 45: 737-741. https://doi.org/10.1080/02713683.2019.1697454
  8. Stewart JM, Cubillan LD, Cunningham ET, Jr. Prevalence, clinical features, and causes of vision loss among patients with ocular toxocariasis. Retina 2005; 25: 1005-1013. https://doi.org/10.1097/00006982-200512000-00009
  9. Kong L, Peng HJ. Current epidemic situation of human toxocariasis in China. Adv Parasitol 2020; 109: 433-448. https://doi.org/10.1016/bs.apar.2020.01.016
  10. Ahn SJ, Ryoo NK, Woo SJ. Ocular toxocariasis: clinical features, diagnosis, treatment, and prevention. Asia Pac Allergy 2014; 4: 134-141. https://doi.org/10.5415/apallergy.2014.4.3.134
  11. Jee D, Kim KS, Lee WK, Kim W, Jeon S. Clinical features of ocular toxocariasis in adult Korean patients. Ocul Immunol Inflamm 2016; 24: 207-216. https://doi.org/10.3109/09273948.2014.994783
  12. Pak KY, Park SW, Byon IS, Lee JE. Ocular toxocariasis presenting as bilateral scleritis with suspect retinal granuloma in the nerve fiber layer: a case report. BMC Infect Dis 2016; 16: 426. https://doi.org/10.1186/s12879-016-1762-1
  13. Yoon DY, Woo SJ. Intravitreal administration of ranibizumab and bevacizumab for choroidal neovascularization secondary to ocular toxocariasis: a case report. Ocul Immunol Inflamm 2018; 26: 639-641. https://doi.org/10.1080/09273948.2016.1239744
  14. Lyall DAM, Hutchison BM, Gaskell A, Varikkara M. Intravitreal Ranibizumab in the treatment of choroidal neovascularisation secondary to ocular toxocariasis in a 13-year-old boy. Eye (Lond) 2010; 24: 1730-1731. https://doi.org/10.1038/eye.2010.131
  15. Znaor L, Medic A, Binder S, Vucinovic A, Marin Lovric J, Puljak L. Pars plana vitrectomy versus scleral buckling for repairing simple rhegmatogenous retinal detachments. Cochrane Database Syst Rev 2019; 3: CD009562. https://doi.org/10.1002/14651858.CD009562.pub2
  16. Ahn SJ, Woo SJ, Jin Y, Chang YS, Kim TW, Ahn J, Heo JW, Yu HG, Chung H, Park KH, Hong ST. Clinical features and course of ocular toxocariasis in adults. PLoS Negl Trop Dis 2014; 8: e2938. https://doi.org/10.1371/journal.pntd.0002938
  17. Takakura A, Tessler HH, Goldstein DA, Guex-Crosier Y, Chan CC, Brown DM, Thorne JE, Wang R, Cunningham ET Jr. Viral retinitis following intraocular or periocular corticosteroid administration: a case series and comprehensive review of the literature. Ocul Immunol Inflamm 2014; 22: 175-182. https://doi.org/10.3109/09273948.2013.866256